about
Posterior reversible encephalopathy syndrome in childhood with hematologic/oncologic diseases.Efficacy of tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma: the Korean Society of Pediatric Hematology-Oncology experience over 6 years (2000-2005).Efficacy and safety of deferiprone (Ferriprox), an oral iron-chelating agent, in pediatric patients.Clinical outcome of relapsed or refractory burkitt lymphoma and mature B-cell lymphoblastic leukemia in children and adolescents.Treatment Outcome and Prognostic Molecular Markers of Supratentorial Primitive Neuroectodermal Tumors.Clinical and hematologic manifestations in patients with Diamond Blackfan anemia in Korea.Role of Radiotherapy in the Multimodal Treatment of Ewing Sarcoma Family Tumors.Patterns of Failure Following Multimodal Treatment for Medulloblastoma: Long-Term Follow-up Results at a Single InstitutionSymptom Interval and Patient Delay Affect Survival Outcomes in Adolescent Cancer PatientsIncreasing and worsening late effects in childhood cancer survivors during follow-up.A der(1;15)(q10;q10) is a rare nonrandom whole-arm translocation in patients with acute lymphoblastic leukemia.Clinical role of bone marrow angiogenesis in childhood acute lymphocytic leukemiaFrequency and Clinical Characteristics of Intrachromosomal Amplification of Chromosome 21 in Korean Childhood B-lineage Acute Lymphoblastic LeukemiaSubclinical Hypothyroidism in Childhood Cancer Survivors.Characteristics and Outcomes of Second Malignant Neoplasms after Childhood Cancer Treatment: Multi-Center Retrospective Survey.Hereditary hemolytic anemia in Korea from 2007 to 2011: A study by the Korean Hereditary Hemolytic Anemia Working Party of the Korean Society of Hematology.Colon carcinoma in childhood: review of the literature with four case reports.Quantitative computed tomography assessment of graft-versus-host disease-related bronchiolitis obliterans in children: A pilot feasibility study.The outcome of hematopoietic stem cell transplantation in Korean children with hemophagocytic lymphohistiocytosis.Recombinant urate oxidase (Rasburicase) for the treatment of hyperuricemia in pediatric patients with hematologic malignancies: Results of a compassionate prospective multicenter study in Korea.Poor bone health at the end of puberty in childhood cancer survivors.Factors Associated with Emotional Distress in Children and Adolescents during Early Treatment for CancerFeasibility of sequential high-dose chemotherapy in advanced pediatric solid tumors.Prevalence of type 5 familial hemophagocytic lymphohistiocytosis in Korea and novel mutations in STXBP2.Cytomegalovirus infection in seropositive unrelated cord blood recipients: a study of 349 Korean patients.Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party.Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation.Clinical features and treatment outcomes of Langerhans cell histiocytosis: a nationwide survey from Korea histiocytosis working party.Second primary brain tumors following cranial irradiation for pediatric solid brain tumors.Population-specific spectrum of the F11 mutations in Koreans: evidence for a founder effect.Outcomes of Treatment for Malignant Peripheral Nerve Sheath Tumors: Different Clinical Features Associated with Neurofibromatosis Type 1.Clinical Risk Factors Influencing Dental Developmental Disturbances in Childhood Cancer Survivors.Predictors of general discomfort, limitations in activities of daily living and intention of a second donation in unrelated hematopoietic stem cell donation.Impact of psychological and cancer-related factors on HRQoL for Korean childhood cancer survivors.A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors.Comprehensive clinical follow-up of late effects in childhood cancer survivors shows the need for early and well-timed intervention.Favorable outcome of alternate systemic and intra-arterial chemotherapy for retinoblastoma.Epidemiology and clinical long-term outcome of childhood aplastic anemia in Korea for 15 years: retrospective study of the Korean Society of Pediatric Hematology Oncology (KSPHO).Prognostic value of pretreatment FDG PET in pediatric neuroblastoma.Efficacy and safety of micafungin for the prophylaxis of invasive fungal infection during neutropenia in children and adolescents undergoing allogeneic hematopoietic SCT.
P50
Q33476111-069E177A-6D4D-4344-9BD9-F12953DDDAF8Q33807214-BC6173D6-5D6E-44F4-B8F4-2F7B103AA6B9Q34316787-189FBD8E-307C-4EC9-9D74-12CB5F7EDD7FQ34386029-0D2897D3-B9C0-43DF-A15B-A808B996D7D1Q35988515-EB2A2F1D-4D97-4E48-9914-9C66E4097711Q36074032-5B6A8751-DFF8-4FEF-8173-D9044E6D1209Q36187024-64709B5C-1152-44AD-8A16-7DC11F962394Q36187109-5B780FAB-4794-4166-9C9E-3D253BD5C2C5Q36707868-E631CC53-9E9C-4177-BC1F-7F9DF6B8430DQ36841132-000B0613-F933-4F97-B925-EEE84DBD692FQ37013228-4ECC0AD7-3C8E-45B4-95A7-AA94767ABFA7Q37065537-614A46F9-5B71-4B06-9FFC-9033F83D609BQ37084156-602E9D33-8000-48B1-81AB-2542176DEAA2Q37110184-88DC170C-3D7A-4F6D-AA42-2B0D0E03E7F3Q37110485-40879A95-733E-48C3-9D1D-EF8B3FFBBE44Q37205602-FC8F3704-B853-41EA-89F5-14BA3DCB10C6Q38055677-8EAAEE85-CCE2-49F2-B0C2-3B03871CD174Q38391378-D3A50266-2D00-4DE1-8D6E-977D23BBB923Q38488933-C25C00F5-986C-4104-866D-E6E75A486AD3Q38513160-B96CF244-AD21-472D-999B-326E0D9CA38EQ39007257-B7CEAADC-0F69-4F41-848E-7ECD47AD15B5Q39328402-A0698827-B3DE-47FD-925A-113C1F53A8D8Q40367329-6F961EB3-7AE0-44F7-B562-8DB2A1D56632Q40448774-873336BE-1323-43C9-9518-61E57A4CA86DQ41651915-92888EA6-A760-496E-87A8-3126E5F52B27Q42212147-8125A618-3878-49D1-9F2A-3B7A6A56F94AQ42380314-0C9E8A3A-EE9A-45BD-BC6F-B921F29B37E3Q44296665-879A6DCD-B8B6-4D09-91C8-358C83FE876EQ44931949-D920BDA9-DEDE-401A-A788-72A48AF0DD87Q46488118-36B370AD-5CC7-4998-918D-6C3615D13186Q47593298-1D137650-1322-415B-9511-A66D91D1F2E3Q47903412-F303EB46-69E3-4E78-ADB7-4565652D3CEFQ47953542-71D44C47-89BB-47EF-AAE2-319554DEE1A8Q48076828-9C513EA1-F0FB-4B44-910F-9978C3C778BAQ48613948-42770475-ECDB-4D8C-8AD7-EC368B544ADBQ48712962-1D74F070-29AA-42F7-AE41-75BB811ED510Q48861825-CD70DD30-2700-4374-B2F1-884C3DEB683AQ51158944-C5EE5D63-0980-44A0-984D-2E9910C59777Q52990309-3B2EAD1E-E19D-4937-88B0-AAEE410D6EFCQ53271427-239FA588-4C2C-4BE4-A709-23EC77A40321
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Chuhl Joo Lyu
@ast
Chuhl Joo Lyu
@en
Chuhl Joo Lyu
@es
Chuhl Joo Lyu
@nl
type
label
Chuhl Joo Lyu
@ast
Chuhl Joo Lyu
@en
Chuhl Joo Lyu
@es
Chuhl Joo Lyu
@nl
prefLabel
Chuhl Joo Lyu
@ast
Chuhl Joo Lyu
@en
Chuhl Joo Lyu
@es
Chuhl Joo Lyu
@nl
P31
P496
0000-0001-7124-7818